Characterization of fibrin degradation products in patients on ancrod therapy: comparison with fibrinogen derivatives produced by plasmin.
D002850:Chromatography, Gel; D005337:Fibrin / Q000378:metabolism*; D005340:Fibrinogen / Q000378:metabolism; D005341:Fibrinolysin / Q000378:metabolism*; D006801:Humans; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D008970:Molecular Weight; D010447:Peptide Hydrolases / Q000627:therapeutic use*; D013927:Thrombosis / Q000188:drug therapy; D014688:Venoms / Q000627:therapeutic use*
D014688:Venoms; D005337:Fibrin; D005340:Fibrinogen; D010447:Peptide Hydrolases; D005341:Fibrinolysin